xevinapant
Showing 1 - 5 of 5
Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)
Not yet recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Xevinapant
- +3 more
- (no location specified)
Jul 3, 2023
Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,
Not yet recruiting
- Head and Neck Cancer
- +2 more
- Xevinapant
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023
Head Neck Cancer Trial in Billerica, Darmstadt (Xevinapant, Cisplatin, intensity-modulated radiation therapy (IMRT))
Not yet recruiting
- Head and Neck Cancer
- Xevinapant
- +2 more
-
Billerica, Massachusetts
- +1 more
Sep 20, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Xevinapant, Placebo)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Xevinapant
- Placebo
- (no location specified)
Feb 10, 2023
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Biospecimen Collection
- +9 more
- (no location specified)
Oct 10, 2023